The european molecular genetics quality network (emqn) has issued best practice guidelines for the laboratory diagnosis of various genetic disorders. These guidelines cover a range of conditions, including osteogenesis imperfecta, huntington disease, and prader-willi and angelman syndromes, among others. The guidelines appear to be part of a broader effort to establish standards for molecular genetic testing and reporting in clinical genetics laboratories.